Literature DB >> 475963

Inhibition of DNA synthesis by nitroheterocycles. I. Correlation with half-wave reduction potential.

P L Olive.   

Abstract

Twenty-one nitroheterocycles, including metronidazole, misonidazole and AF-2, were tested for their ability to inhibit DNA synthesis in mouse L-929 cells growing in culture. All those tested inhibited the rate of incorporation of 3H-thymidine into L cells following drug treatment for 4 h under aerobic conditions. Only 4 drugs reached their limits of solubility before the uptake of 3H-thymidine was inhibited by 50% or more. For the remaining 17, the log of the concentration producing 50% inhibition of incorporation was directly correlated with the half-wave reduction potential of the compound.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475963      PMCID: PMC2009968          DOI: 10.1038/bjc.1979.144

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Polarographic study of nitrofuran derivatives. II. Reduction potential of nitrofuran derivatives and nitrobenzene analogs.

Authors:  T SASAKI
Journal:  Pharm Bull       Date:  1954-06

2.  The mechanism of microsomal and mitochondrial nitroreductase. Electron spin resonance evidence for nitroaromatic free radical intermediates.

Authors:  R P Mason; J L Holtzman
Journal:  Biochemistry       Date:  1975-04-22       Impact factor: 3.162

3.  Electron spin resonance-spin trapping. Detection of superoxide formation during aerobic microsomal reduction of nitro-compounds.

Authors:  R C Sealy; H M Swartz; P L Olive
Journal:  Biochem Biophys Res Commun       Date:  1978-05-30       Impact factor: 3.575

4.  Oxygen inhibition of nitroreductase: electron transfer from nitro radical-anions to oxygen.

Authors:  P Wardman; E D Clarke
Journal:  Biochem Biophys Res Commun       Date:  1976-04-19       Impact factor: 3.575

5.  Activation of radiosensitizers by hypoxic cells.

Authors:  P L Olive; R E Durand
Journal:  Br J Cancer Suppl       Date:  1978-06

6.  Action of some nitrofuran derivatives on glucose metabolism, ATP levels, and macromolecule synthesis in Escherichia coli.

Authors:  C Lu; D R McCalla
Journal:  Can J Microbiol       Date:  1978-06       Impact factor: 2.419

Review 7.  Errors in DNA replication as a basis of malignant changes.

Authors:  L A Loeb; C F Springgate; N Battula
Journal:  Cancer Res       Date:  1974-09       Impact factor: 12.701

8.  Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to x rays.

Authors:  J D Chapman; A P Reuvers; J Borsa
Journal:  Br J Radiol       Date:  1973-08       Impact factor: 3.039

9.  Electronic aspect of the antibacterial activity of nitrofuran derivatives.

Authors:  K Hirano; S Yoshina; K Okamura; I Suzuka
Journal:  Bull Chem Soc Jpn       Date:  1967-10       Impact factor: 5.488

10.  Inhibition of DNA synthesis by nitroheterocycles. II. Mechanisms of cytotoxicity.

Authors:  P L Olive
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

View more
  5 in total

1.  Isobutyl 3,5-dinitro-benzoate.

Authors:  Pei Zou; Min-Hao Xie; Shi-Neng Luo; Ya-Ling Liu; Yong-Jun He
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-28

2.  Metronidazole decreases viability of DLD-1 colorectal cancer cell line.

Authors:  Anna Sadowska; Rafał Krętowski; Beata Szynaka; Marzanna Cechowska-Pasko; Halina Car
Journal:  Cancer Biother Radiopharm       Date:  2013-06-18       Impact factor: 3.099

Review 3.  Structure-activity relationships in the free-radical metabolism of xenobiotics.

Authors:  C F Chignell
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

4.  Inhibition of DNA synthesis by nitroheterocycles. II. Mechanisms of cytotoxicity.

Authors:  P L Olive
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

5.  Interaction of nitroimidazole drugs with DNA in vitro: structure-activity relationships.

Authors:  R J Knox; R C Knight; D I Edwards
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.